Table 6: Recommendations related to treatment of hypertension and seizures in pregnancy issued by the Canadian Hypertension Society (CHS) and other international bodies* | |||
Category | CHS | NHBPEPWG99 | ASSH100 |
Nonsevere hypertension |
|||
BP readings at which to start treatment, mm Hg | SBP > 139 or 149 or DBP > 89 or 94 |
DBP > 99 | SBP > 159 or
DBP > 89 |
Treatment goal, mm Hg | DBP 80-90 | -- | SBP > 110 |
Drugs | Methyldopa, labetalol, pindolol, oxprenolol, nifedipine | Methyldopa | Methyldopa, labetalol, oxprenolol, clonidine |
Drugs to avoid | ACE inhibitor, angiotensin II receptor antagonist | ACE inhibitor | ACE inhibitor, diuretics |
Severe hypertension |
|||
BP readings at which to start treatment, mm Hg | SBP > 169 or DBP >109 |
DBP > 104 | SBP > 169 or DBP > 114 |
Drugs | Hydralazine, labetalol, nifedipine | Hydralazine | Hydralazine, labetalol nifedipine, diazoxide |
Seizures |
|||
Drugs for prophylaxis | Magnesium sulfate | Magnesium sulfate | Magnesium sulfate, phenytoin |
Drugs for treatment | Magnesium sulfate | Magnesium sulfate | Diazepam intravenously |
*NHBPEPWG = National High Blood Pressure Education Program Working Group (US), ASSH = Australasian Society for Study of Hypertension. |